Founded in 1995, Abacus International started life as a specialist health economics consultancy. Since then, we have evolved into a global provider of integrated market access services. In this time, the market access landscape for pharmaceutical and medical devices companies has changed immeasurably. Payers, and not prescribers, have become the primary decision makers; health technology assessment (HTA) bodies have emerged worldwide; and, most recently, we have seen the trend towards value-based pricing in place of free or reference pricing. As our environment has changed, however, Abacus International has always innovated and adapted to our surroundings – evolving our market access consultancy offering to meet the ever-changing needs of our clients. Today, our integrated market access services deliver effective health economic and evidence-based solutions across the product lifecycle: Payer Insight and Reimbursement Strategy – plan for success Systematic review – evaluate the evidence Health economics – develop cost-based value argument Clinical outcomes assessment – Develop and validate patient-centred outcome measures Health technology assessment – achieve positive recommendations Value communication – maximise access & uptake Strategic market access planning & consultancy